(QQQL) Global X Enhanced - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: (N/A)

Description: QQQL Global X Enhanced

Index: Morningstar CAD O/N Cash GR CAD

Additional Sources for QQQL ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

QQQL ETF Overview

Market Cap in USD 3m
Category Alternative Equity Focused
IPO / Inception 2024-05-21

QQQL ETF Ratings

Growth Rating 39.9
Fundamental -
Dividend Rating 0.0
Rel. Strength 2.77
Analysts -
Fair Price Momentum 22.25 CAD
Fair Price DCF -

QQQL Dividends

Currently no dividends paid

QQQL Growth Ratios

Growth Correlation 3m 93.2%
Growth Correlation 12m 46.8%
Growth Correlation 5y 58.1%
CAGR 5y 22.55%
CAGR/Max DD 5y 0.81
Sharpe Ratio 12m -0.14
Alpha 6.86
Beta 1.454
Volatility 15.45%
Current Volume 8.5k
Average Volume 20d 0.4k
Stop Loss 24.7 (-3.1%)
What is the price of QQQL shares?
As of August 02, 2025, the stock is trading at CAD 25.48 with a total of 8,450 shares traded.
Over the past week, the price has changed by -1.96%, over one month by +2.29%, over three months by +20.64% and over the past year by +24.54%.
Is Global X Enhanced a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Global X Enhanced (TO:QQQL) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.90 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of QQQL is around 22.25 CAD . This means that QQQL is currently overvalued and has a potential downside of -12.68%.
Is QQQL a buy, sell or hold?
Global X Enhanced has no consensus analysts rating.
What are the forecasts for QQQL share price target?
According to our own proprietary Forecast Model, QQQL Global X Enhanced will be worth about 26.7 in August 2026. The stock is currently trading at 25.48. This means that the stock has a potential upside of +4.83%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.7 4.8%